Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromatin structural elements and chromosomal translocations in leukemia.

Yanming Zhang1, Janet D Rowley

  • 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Chicago, IL, USA.

DNA Repair
|August 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclin D1-negative and SOX11-positive B-cell lymphoma with CD5 and CD10 coexpression and <i>MYC</i> rearrangement: A diagnostic challenge.

EJHaem·2024
Same author

Influence of phloretin on acrolein-induced protein modification and physicochemical changes in a dairy protein model.

Food chemistry: X·2024
Same author

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.

Blood cancer journal·2024
Same author

Enhancing Variant Calling in Whole-exome Sequencing Data Using Population-matched Reference Genomes.

Genomics, proteomics & bioinformatics·2024
Same author

Blood-derived factors to brain communication in brain diseases.

Science bulletin·2024
Same author

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

bioRxiv : the preprint server for biology·2024

Chromosome translocations are key in leukemia and cancer prognosis. Research suggests non-homologous recombination mechanisms, involving DNA repair pathways, drive these critical genetic alterations.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Recurring chromosome abnormalities are strongly linked to leukemia, lymphoma, sarcomas, and increasingly, carcinomas like prostate cancer.
  • These abnormalities are critical prognostic factors and guide treatment protocols.
  • Chromosome translocations are common in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), but their formation mechanisms remain largely unknown.

Purpose of the Study:

  • To investigate the mechanisms underlying chromosome translocations in leukemia.
  • To identify common genomic breakpoints and associated genetic elements in leukemia-associated translocations.
  • To propose a model for the formation of chromosome translocations in leukemia.

Main Methods:

  • Cloning of genomic breakpoints for common leukemia translocations (e.g., t(4;11), t(9;22)).

Related Experiment Videos

  • Mapping of chromatin structural elements (topoisomerase II cleavage sites, DNase I hypersensitive sites, scaffold attachment regions) at breakpoint regions.
  • Analysis of DNA repair signatures (non-homologous end joining) at translocation junctions.

    • Main Results:

    • Genomic breakpoints cluster in specific intronic regions of genes like MLL, AML1, and ETO.
    • Topoisomerase II cleavage sites and DNase I hypersensitive sites often co-localize with breakpoints.
    • A strong non-homologous end joining (NHEJ) repair signature, including deletions and duplications, is present at all analyzed translocation junctions.
    • Deletions/duplications are larger in de novo leukemia compared to therapy-related leukemia.

    Conclusions:

    • A non-homologous chromosome recombination model is proposed for translocation formation in leukemia.
    • Vulnerable DNA regions (e.g., topoisomerase II sites, open chromatin) are likely initial breakage sites.
    • Excision-joining repair processes contribute to the formation of these translocations.